Roy L. Silverstein

Affiliations: 
Cell Biology Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
Cell Biology
Google:
"Roy Silverstein"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang M, Silverstein RL. (2024) Targeting Cysteine Oxidation in Thrombotic Disorders. Antioxidants (Basel, Switzerland). 13
Zhang Z, Dai W, Zhu W, et al. (2023) Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19. Research and Practice in Thrombosis and Haemostasis. 7: 102164
Pillai SS, Pereira DG, Zhang J, et al. (2023) Contribution of adipocyte Na/K-ATPase α1/CD36 signaling induced exosome secretion in response to oxidized LDL. Frontiers in Cardiovascular Medicine. 10: 1046495
Huang W, Li R, Zhang J, et al. (2022) A CD36 transmembrane domain peptide interrupts CD36 interactions with membrane partners on macrophages and inhibits atherogenic functions. Translational Research : the Journal of Laboratory and Clinical Medicine
Zhang J, Chang J, Beg MA, et al. (2022) Na/K-ATPase suppresses LPS-induced pro-inflammatory signaling through Lyn. Iscience. 25: 104963
Kim SY, Jeong SJ, Park JH, et al. (2022) Plasma Membrane Localization of CD36 Requires Vimentin Phosphorylation; A Mechanism by Which Macrophage Vimentin Promotes Atherosclerosis. Frontiers in Cardiovascular Medicine. 9: 792717
Chen Y, Zhang J, Cui W, et al. (2022) CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. The Journal of Experimental Medicine. 219
Dai W, Lund H, Chen Y, et al. (2021) Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19. Journal of Clinical Lipidology
Palma FR, Ratti BA, Paviani V, et al. (2021) AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism. Oncogene
Palma FR, Ratti BA, Paviani V, et al. (2021) AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism. Oncogene
See more...